Comparison of long-term efficacy between concurrent chemoradiotherapy and intensity-modulated radiotherapy alone for stage Ⅱ nasopharyngeal carcinoma

孙学明,陈春燕,韩非,卢泰祥

DOI: https://doi.org/10.3760/cma.j.issn.1004-4221.2017.04.002

2017-01-01

Abstract:Objective To compare the long-term efficacy between intensity-modulated radiotherapy (IMRT) alone and concurrent chemoradiotherapy (CCRT) in the treatment of stage Ⅱ nasopharyngeal carcinoma (NPC) patients.Methods The clinical data of 123 patients with stage Ⅱ NPC were retrospectively analyzed.Eighty-one patients received IMRT alone,and 42 patients received CCRT.The Kaplan-Meier method was used to calculate survival rates,and the log-rank test was used to compare the survival rates.Results The 5-year overall survival (OS),local recurrence-free survival (LRFS),distant metastasis-free survival (DMFS),and progression-free survival (PFS) rates in all patients were 96.7％,94.7％,93.1％,and 87.8％,respectively.There were no significant differences between the patients receiving IMRT alone and CCRT in 5-year OS (98.7％ vs.92.9％,P=0.569),LRFS (94.8％ vs.94.5％,P =0.770),DMFS (94.5％ vs.90.2％,P =O.408),and PFS (90.6％ vs.82.2％,P =0.340).For patients with stage T2N1 NPC,the 5-year OS,LRFS,DMFS,and PFS also showed no significant differences between those receiving IMRT alone and CCRT (P=0.929,0.967,0.917,0.492).The incidence rates of neutropenia,leukopenia,and mucositis were significantly higher in patients receiving CCRT than in those receiving IMRT alone (P=0.000,0.000,0.012,0.010),while the incidence of late toxicities was similar between the two groups of patients (P=O.823,0.622,O.113).Conclusions For stage Ⅱ NPC patients treated with IMRT,the addition of concurrent chemotherapy fails to improve the prognosis,and increases the incidence of acute toxicities.